Today is May 23, 2024. All times in Eastern Daylight Time.
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
05/23/2024 - 05:00 PM
BUSINESS WIRE
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
Klaviyo to Present at the William Blair Growth Stock Conference
05/23/2024 - 05:00 PM
BUSINESS WIRE
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
05/23/2024 - 05:00 PM
BUSINESS WIRE
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
05/23/2024 - 05:00 PM
BUSINESS WIRE
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
05/23/2024 - 05:00 PM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1825
« Previous
Next »